| Osisko Gold Announces Formal Construction Decision and Development Update for the Cariboo Gold Project |
Globe Newswire |
09/14 |
07:00 |
| Kaplan Fox Alerts Investors of Microvast Holdings, Inc. (NASDAQ: MVST) with Significant Losses to a Securities Class Action Deadline on September 21, 2026 |
Globe Newswire |
09/14 |
07:00 |
| AirJoule Technologies Acquires BitSink, Adding Profitable AI & HPC Infrastructure Cooling Business |
Globe Newswire |
09/14 |
07:00 |
| Brazil Potash Reduces Upfront Capex with 28-Year Construction & Backup Power Contract |
Globe Newswire |
09/14 |
07:00 |
| INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board |
Globe Newswire |
09/14 |
07:00 |
| Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference |
Globe Newswire |
09/14 |
07:00 |
| GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS) |
Globe Newswire |
09/14 |
07:00 |
| Ashland Innovation Day to be held September 17, 2026 |
Globe Newswire |
09/14 |
07:00 |
| Dataprana Welcomes Land and Power Executives Amid US Data Center Market Expansion |
Globe Newswire |
09/14 |
07:00 |
| Talisker Provides 2026 Operational Update |
Globe Newswire |
09/14 |
07:00 |
| Highwoods Announces Leasing and Disposition Activity |
Globe Newswire |
09/14 |
07:00 |
| VisionWave Files U.S. Non-Provisional Patent Application Describing ARGUS™, a Proposed Space-Enabled, AI-Driven Counter-Drone Defense Architecture |
Globe Newswire |
09/14 |
07:00 |
| Macerich To Present at BofA Securities 2026 Global Real Estate Conference |
Globe Newswire |
09/14 |
07:00 |
| Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma |
Globe Newswire |
09/14 |
07:00 |
| Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development |
Globe Newswire |
09/14 |
07:00 |
| Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification |
Globe Newswire |
09/14 |
07:00 |
| Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days |
Globe Newswire |
09/14 |
07:00 |
| Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity |
Globe Newswire |
09/14 |
07:00 |
| Village Farms Appoints Deepak Anand to Lead Global Government Affairs |
Globe Newswire |
09/14 |
07:00 |
| Brand Naming: Brand Acumen Details the Evaluation Behind Product Names Still in Use After 25 Years |
Globe Newswire |
09/14 |
07:00 |
| Coda Octopus Group Reports Fiscal Third Quarter 2026 Financial Results |
Globe Newswire |
09/14 |
07:00 |
| Slate Medicines Appoints Kenneth Koblan, PhD, as Chief Scientific Officer |
Globe Newswire |
09/14 |
07:00 |
| Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act |
Globe Newswire |
09/14 |
06:55 |
| YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST |
Globe Newswire |
09/14 |
06:55 |
| Hain Celestial Reports Fiscal Fourth Quarter and Fiscal Year 2026 Financial Results |
Globe Newswire |
09/14 |
06:48 |
